NK Cells Infusions With Irinotecan, Temozolomide, and Dinutuximab

Clinical trial NCT04211675 · RECRUITING

Trial details

NCT number: NCT04211675
Sponsor: Nationwide Children's Hospital
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Relapsed Neuroblastoma Refractory Neuroblastoma

Start date: 2022-09-01
Primary completion: 2026-12-01
Enrollment: 31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.